A Phase 1 Study of Single and Multiple Ascending Doses of GV-100

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This is a first‐in‐human, multi‐part clinical study designed to evaluate the safety,tolerability, pharmacokinetics (PK), food effect, and drug‐drug interaction (DDI)potential of GV‐100 following oral administration in healthy participants. The study isdivided into four parts: Single Ascending Dose (SAD), Multiple Ascending Dose (MAD), FoodEffect (FE), and Drug‐Drug Interaction (DDI).
Epistemonikos ID: 8c599eca59dc5b15d1e429f6bc7546f65f72caf2
First added on: Aug 26, 2026